€
About Us
About Royal Sense
Vision & Values
Board of Directors
Quality
Our Offerings
Pharmaceuticals
IVD Products
Orthotics
Medical Devices
Sutures
Investors
Corporate Governance
Disclosure Under Regulation 46
Disclosure under Regulation 30
Annual Report of Subsidiary Company
Newspaper Advertisement
Half Yearly Financials
Quater Results
Investor Contact
Board Meeting
2024-25
2025-26
Investor Contact
Quaterly Compliances
December-2024
June 2024
June 2025
March 2024
March 2025
September-2024
Investor Contact
Shareholding Pattern
Investors Grievance Regulation 13(3)
Disclosure under 30 of SEBI LODR
Annual Returns
Newspaper publication
Annual Reports
Regulation 74(5)
Regulation 7(3)
Regulation 40(9)
Regulation 23(9)
General Meetings
Merger
Media
Media Release
Announcements
Partner With Us
Carrier
Available Roles
Deceptive Hiring Practices
Contact Us
Disclosure under Regulation 30
Intimation under Reg 30_product launch
Intimation under Reg 30_product launch
Intimation of appointment of Independent director
Intimation For Resignation of Independent Directors
Intimation for Internal auditors appointment
Intimation for appointment of Secretarial auditor
4.09.2024
6.09.2024
Corporate Announcement_Product Launch
Corporate Announcement_Royal Sense
Announcement_HBSAG Product.pdf
Announement_Royal Sense
Corp Announcement_03.04.2025
Corp Announcement_13.02.2025
Corporate Announcement_03.10.2024
Corporate Announcement_5.03.2025
Corporate Announcement_06.01.2024
Corporate Announcement_13.09.2024
Corporate Announcement_14.01.2025
Corporate Announcement_16.07.2024
Corporate Announcement_18.07.2024
Corporate Announcement_20.08.2024
Corporate Announcement_21.08.2024.pdf
Corporate Announcement_23.07.2024
Corporate Announcement_23.08.2024
Corporate Announcement_25.10.2024
Corporate Announcement_26.07.2024
Corporate Announcement_28.08.2024
Corporate Announcement_Nebuliazer
Corporate Announcement_Product Launch
CORPORATE ANNOUNCEMENT_PRODUCT_15.05.2024
Corporate Announcement_Royal Sense
croporate Announcemnt.pdf
Intimation_New Products Launch
outcome
FDA Approval-Corporate Announcemet
ZEPTO&BLINKIT ANNOUNCEMENT
disclosure
Corporate Announcement_FDA Approval
Board Meeting Outcome_15.11.2024
15.01.2025
Effortless well-being
Prepared to handle an extensive
range of pharmaceutical & surgical supplies,
tools, equipment, and related items."
let's chat
STAY CONNECTED